Department of Geriatrics, The First Hospital of Jilin University, Changchun, 130021, People's Republic of China.
School of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China.
Biomed Pharmacother. 2018 Mar;99:33-42. doi: 10.1016/j.biopha.2018.01.039. Epub 2018 Jan 8.
Oxidative stress injury and apoptosis are the main mechanisms of myocardial ischemia-reperfusion injury (MI/RI). Compounds with anti-oxidant properties can treat MI/RI. Therefore, identification of natural antioxidants such as herbs or botanical drugs is an ideal strategy to develop safe and effective anti-MI/RI drugs. Cardioprotective effects of Ginseng are well documented and are attributable to its anti-oxidant, anti-inflammatory, anti-tumorigenic, anti-arrhythmic, anti-ischemic properties. Ginseng monomer 20-dammarane -3 beta,6 alpha,12 beta,20,25-pentol(25-hydroxyl-Protopanaxatriol,25-OH-PPT), a novel compound, which belongs to panaxatriol category, is extracted from the leaves and stem of ginseng. It was first investigated for its anti-tumorigenic properties. In this study, we explored whether 25-OH-PTT plays a role in antioxidant stress injury and anti-apoptosis in cardiomyocytes. We also explored the mechanisms in order to provide a theoretical basis to develop 25-OH-PPT as a new drug for treatment of MI/RI. First, we used HO to induce H9c2 cardiomyocytes in vitro resulting in an oxidative stress injury model and pretreated with 25-OH-PPT. Secondly, we examined the viability of H9c2 cells by MTT assay, the reactive oxygen species (ROS) content and mitochondrial membrane potential by flow cytometry as well as cell apoptosis by flow cytometry Annexin-FITC/PI and Hoechst 33258 staining. Furthermore, we pretreated H9c2 cells with PI3K inhibitor, LY294002, and observed the above phenomenon. Lastly, we examined the expressions of proteins related to the PI3K/Akt signaling pathway and the apoptotic proteins. We found that 25-OH-PPT can protect H9c2 cells against HO-induced injury, decrease apoptosis of H9c2 cells and ROS generation, and increase the mitochondrial membrane potential. It can also upregulate the protein expressions of p-Akt, p-eNOS, and Bcl-2 and down-regulate apoptotic proteins Bax and Caspase-3. Our results indicate that 25-OH-PPT inhibits HO-induced H9c2 cardiomyocytes injury through PI3K/Akt pathway. It may become a potential safe and effective traditional Chinese medicine monomer for treatment of MI/RI.
氧化应激损伤和细胞凋亡是心肌缺血再灌注损伤(MI/RI)的主要机制。具有抗氧化特性的化合物可以治疗 MI/RI。因此,鉴定草药或植物药等天然抗氧化剂是开发安全有效的抗 MI/RI 药物的理想策略。人参的心脏保护作用已有充分的记载,这归因于其抗氧化、抗炎、抗肿瘤、抗心律失常、抗缺血作用。人参单体 20-达玛烷-3β,6α,12β,20,25-五醇(25-羟基-原人参三醇,25-OH-PPT),一种新型化合物,属于人参三醇类,从人参的叶和茎中提取。它最初是因其抗肿瘤特性而被研究的。在这项研究中,我们探讨了 25-OH-PTT 是否在心肌细胞的抗氧化应激损伤和抗细胞凋亡中发挥作用。我们还探讨了其机制,以期为开发 25-OH-PPT 作为治疗 MI/RI 的新药提供理论依据。首先,我们使用 HO 在体外诱导 H9c2 心肌细胞,导致氧化应激损伤模型,并使用 25-OH-PPT 预处理。其次,通过 MTT 测定法检测 H9c2 细胞的活力,通过流式细胞术检测活性氧(ROS)含量和线粒体膜电位,通过流式细胞术 Annexin-FITC/PI 和 Hoechst 33258 染色检测细胞凋亡。此外,我们用 PI3K 抑制剂 LY294002 预处理 H9c2 细胞,观察上述现象。最后,我们检测了与 PI3K/Akt 信号通路和凋亡蛋白相关的蛋白质的表达。结果发现,25-OH-PPT 可以保护 H9c2 细胞免受 HO 诱导的损伤,减少 H9c2 细胞凋亡和 ROS 的产生,并增加线粒体膜电位。它还可以上调 p-Akt、p-eNOS 和 Bcl-2 的蛋白表达,下调凋亡蛋白 Bax 和 Caspase-3。我们的结果表明,25-OH-PPT 通过 PI3K/Akt 通路抑制 HO 诱导的 H9c2 心肌细胞损伤。它可能成为一种有潜力的安全有效的治疗 MI/RI 的中药单体。